Literature DB >> 32248856

Lymphopenia in adults after the Fontan operation: prevalence and associations.

Tarek Alsaied1, Mathias Possner1, Nicole Brown1, Hassan Almeneisi1, Cassandra Szugye1, Andrew T Trout2,3, Omar Niss4, Joseph J Palermo5, Faizeen Zafar1, Jonathan R Dillman2,3, Gruschen R Veldtman1,6, Alexander R Opotowsky1,7, Adam M Lubert1.   

Abstract

Lymphopenia is common in adults who have had a Fontan operation although its aetiology and clinical implications remain unknown. Previous work suggests an association between lymphopenia and both liver disease and splenomegaly. The objective of this study was to assess the prevalence of lymphopenia in adults with a Fontan circulation and evaluate its associations with risk factors and clinical outcomes. Using a retrospective cohort study design, we studied 73 adult Fontan patients (age 25.0 ± 8.4 years) who had a complete blood count and abdominal imaging performed. Patients with protein-losing enteropathy were excluded. Clinical data were extracted from hospital records. The mean white blood cell count was 6580 ± 220/ml with a mean lymphocyte count of 1223 ± 508/ml. Lymphopenia, defined as lymphocyte count <1000/ml, was present in 23 (32%) patients. Patients with lymphopenia had a lower total white blood cell count (5556 ± 2517 versus 7136 ± 1924/ml, p = 0.009) and a lower platelet count (162 ± 69 versus 208 ± 69 k/ml, p = 0.008). Lymphopenia was also associated with findings of portal hypertension, including splenomegaly (36 versus 14%, p = 0.04), varices (22 versus 6%, p = 0.04), and ascites (39 versus 14%, p = 0.02). Lymphopenia did not correlate with any cardiac imaging, haemodynamic or exercise testing variables. In conclusion, lymphopenia is common in adult Fontan patients and is associated with markers of portal hypertension. Larger studies are needed to better define the relationship between lymphopenia and clinical outcomes.

Entities:  

Keywords:  Fontan operation; adult CHD; lymphopenia; portal hypertension; single-ventricle CHD; splenomegaly

Mesh:

Year:  2020        PMID: 32248856     DOI: 10.1017/S1047951120000694

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

Review 1.  Imaging of Fontan-associated liver disease.

Authors:  Jonathan R Dillman; Andrew T Trout; Tarek Alsaied; Anita Gupta; Adam M Lubert
Journal:  Pediatr Radiol       Date:  2020-08-18

2.  Association of Lymphatic Abnormalities with Early Complications after Fontan Operation.

Authors:  Sven Dittrich; Anja Weise; Robert Cesnjevar; Oliver Rompel; André Rüffer; Martin Schöber; Julia Moosmann; Martin Glöckler
Journal:  Thorac Cardiovasc Surg       Date:  2020-12-31       Impact factor: 1.827

3.  Fontan Circulation Associated Organ Abnormalities Beyond the Heart, Lungs, Liver, and Gut: A Systematic Review.

Authors:  Evi Ritmeester; Veerle A Veger; Jelle P G van der Ven; Gabrielle M J W van Tussenbroek; Carine I van Capelle; Floris E A Udink Ten Cate; Willem A Helbing
Journal:  Front Cardiovasc Med       Date:  2022-03-22

4.  Clonal Cytopenia of Undetermined Significance in a Patient with Congenital Wilms' Tumor 1 and Acquired DNMT3A Gene Mutations.

Authors:  Ken Murakami; Yuuta Yamaguchi; Yuko Kida; Yoichiro Morikawa; Hidetoshi Ujiie; Hiroyuki Sugahara; Yasuhito Nannya; Seishi Ogawa; Yuzuru Kanakura
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271

5.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Univentricular Patients From Birth to Follow-Up After Fontan-Predicting Lymphatic Abnormalities.

Authors:  Julia Moosmann; Christian Schroeder; Robert Cesnjevar; Kathrin Rottermann; Annika Weigelt; Sven Dittrich
Journal:  Front Pediatr       Date:  2021-12-08       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.